During activation of the fibrinolytic system plasminogen is converted to plasmin by tissue
plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). t-PA is …

Thrombosis is a major cause of morbidity and mortality in cancer patients. The pathogenesis
of blood coagulation activation in oncological patients is complex and involves both clinical …

Many of patient's deaths with solid tumors are caused by altered pathogenesis coagulation
cascade components and processes in clinics. Therapeutic actions for inhibiting cancer …

The occurrence and distribution of components of fibrinolysis pathways were determined
using immunohistochemical techniques applied to 10 cases of primary carcinoma of the …

Tumor emboli were produced in lungs of Sprague-Dawley rats by iv injection of Walker 256
tumor cells into the tail vein. Tissues were examined by electron microscopy at periods from …

Studies on the role of fibrin in experimental cancer growth should take into account the
following problems: 1) during growth and dissemination of experimental tumours …

Cancer and Blood Coagulation: Molecular Aspects. КОРЗИНА ПОИСК НАВИГАТОР
ЖУРНАЛЫ КНИГИ ПАТЕНТЫ ПОИСК АВТОРЫ ОРГАНИЗАЦИИ КЛЮЧЕВЫЕ СЛОВА …

Tumor growth is characterized by disturbances of hemostatic mechanisms towards
subclinical activation of coagulation. In cancer patients there is an increased risk up to 4-6 …

The association between thrombosis and cancer is well known and the first description of
venous thrombosis as a complication of malignant disease by Trousseau dates back to …

Malignancy affects the hemostatic system and the hemostatic system affects malignancy. In
cancer patients there are a number of coagulation abnormalities which provide the …